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Leucine is transported into E. coli cells by high-affinity transport systems (LIV-I and 
leucine-specific systems) which are sensitive to  osmotic shock and require periplasmic 
binding proteins. In addition leucine is transported by a low-affinity system ( LIV-11) 
which is membrane bound and retained in membrane vesicle preparations. The 
LIV-I system serves for threonine and alanine in addition to  the 3 branched-chain 
amino acids. The LIV-I1 system is more specific for leucine, isoleucine, and valine 
while the high-affinity leucine-specific system has the greatest specificity. 
A regulatory locus, livR at minute 2 2  on the E. coli chromosome produces 
negatively regulated leucine transport and synthesis of the binding proteins. Valine- 
resistant strains have been selected to  screen for transport mutants. High-affinity 
leucine transport mutants that have been identified include a LIV-binding protein 
mutant, livJ, a leucine-specific binding protein mutant l ivK and a nonbinding pro- 
tein component of the LIV-I system, l i v l f .  A fourth mutant, / ivP,  appears to  be re- 
quired only for the low-affinity LIV-I1 system. The existence of this latter mutant 
indicates that LIV-I and LIV-11 are parallel transport systems. The 4 mutations con- 
cerned with high-affinity leucine transport form a closely linked cluster of genes on 
the E. coli chromosome at  minute 74. 
systems suggests that an attenuator site may be operative in its regulation. This com- 
plex regulation appears t o  require a modified leucyl-tRNA along with the transcrip- 
tion termination factor rho. Regulation of leucine transport is also defective in 
relaxed strains. 
in LIV-I activity suggesting a special role of this amino acid in the physiology of E. 
coli. It was shown that the rapid exchange of external leucine for intracellular 
isoleucine via the LIV-I system could create an  isoleucine pseudoauxotrophy and 
account for the leucine sensitivity of E. coli. 
The results of recent studies on the regulation of the high-affinity transport 
Among the branched-chain amino acids only leucine produces regulatory changes 
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E. coli have developed 2 basic types of active transport systems for leucine. One of  
these transport systems is a low-affinity membrane-bound system (LIV-11) and can be 
observed in membrane vesicle preparations described by Kaback (1). High-affinity trans- 
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port systems for leucine (LIV-I and leucine-specific) in E. coli are sensitive t o  osmotic 
shock (2) and require periplasmic binding proteins. The leucine binding proteins have been 
described in various review articles (3-5). The high-affinity LIV-I system has a K, for 
leucine of  lop7 M and also transports isoleucine, valine, threonine, and alanine. The 
leucine-specific system comprises about 20% of the high-affinity transport capacity for 
leucine of wild-type E. coli K-12. The regulation of the high-affinity transport systems 
which respond to  the level of leucine in the medium has been extensively studied in our 
laboratory (6-10). Mutations resulting in a loss of leucine repression have been mapped 
and characterized (6, 10). The mutations livR (signifying a derepression of the LIV-I and 
leucine-specific systems) and IstR (signifying derepression of the leucine-specific system 
and the LIV-I1 systems) determine negatively acting regulatory elements and are genetically 
closely linked. Our current understanding of the regulation of leucine transport suggests 
that leucine interacts with t RNAleu and the leucyl-tFWA synthetase t o  produce this 
regulation. The regulation primarily changes the differential rate of synthesis o f  transport 
components relative to  total cellular proteins (9). We have recently shown that mutations 
that alter the hisT gene which codes for a tRNA modifying enzyme (1 1) and the rho allele 
which codes for a transcription termination factor (1 2) also produce a derepression of leucine 
transport (1 3, 14). These results suggested that an "attenuator" type of regulation obtains 
similar to that described for the regulation of tryptophan (15), histidine (16), and branched- 
chain amino acid (1 1)  biosynthetic pathway enzymes. 
systems for leucine has been aided by our recent identification (17) of  a genetic complex 
which codes for at least 4 functions involved in binding protein expression and LIV-I1 
transport expression. This complex is linked t o  malT on the E. coli genetic map,  approxi- 
mately 180" from the regulatory loci livR and IstR. 
Analysis of the structural components of the high-affinity and low-affinity transport 
METHODS 
Growth Conditions 
Growth supplements for auxotrophic strains when not indicated otherwise were: 
50  pg/ml for all L-amino acids except for L-leucine which was used at a concentration of  
25 pg/ml; thymine 50 pg/ml; vitamins 1 pg/ml, glucose 0.2%. 
For all experiments the medium consisted of a morpholino propane sulfonate- 
buffered salts solution (MOPS) described by Neidhardt et al. (1 8). All supplements were 
either sterilized by filtration through 0.2 ym membrane filters or autoclaved. 
water bath (New Brunswick Scientific Company, Model G-76) that maintained constant 
temperatures between 30 and 41 ? 0.25"C. The platform rotation was approximately 
150 rpm. Cell growth was followed by  monitoring absorbance at 420 nm at room tempera- 
ture using a GCA-McPherson model EU 707-1 2 spectrophotometer. 
Cultures were grown aerobically in 125- or 250-ml erlenmeyer flasks in a shaking 
Isolation of Binding Protein 
determined by equilibrium dialysis as described previously (5). 
Transport Assays 
Routine transport assays, as well as the rapid transport assay variant for screening 
large number of  prospective transport mutants, were performed as described previously (10). 
Binding protein was isolated by the osmotic shock procedure and binding activity 
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Enzymes Assays 
The following enzymes were assayed as referenced: 
Threonine deaminase: (E. C. 4.2.1.6; L-threonine hydrolyase [deaminating] : 
(threonine dehydratase) (19) except that the absorbance of the 2,4-dinitrophenylhydrazone 
derivative of a-ketobutyrate was measured at  530 nm in a Zeiss PMQ2 spectrophotometer. 
Acetohydroxy acid synthetase: (AHAS; acetolactate synthetase, E.C.4.1.3.18) (20) 
3-isopropylmalate dehydrogenase (IPMP; 2-hydroxy-4-methyl-3-carboxyvalerate- 
nicotinamide adenine dinucleotide oxidoreductase. E. C. 1.1.1.85) (21). 
Mu Phage Procedure 
Wild type Mu-1 and Mucrs 62 lysates were prepared as already described (17). 
Mu Mutagenesis 
E. coli cultures were grown to a density of 2 X lo8 cells/ml in LBT broth supple- 
mented with 0.01 M MgS04 and mutagenized by  adding Mu or M u m  phage to  a multi- 
plicity of infection of 1 .O. After lysis at the appropriate temperature (37°C for Mu, 30°C 
for M u m )  the cultures were allowed to  grow overnight. Procedures for detecting Mu lyso- 
geny have been previously described (1 7). 
SDS-Polyacrylamide Gel Electrophoresis 
Slab gels containing 1 1% acrylamide and 0.1% SDS (sodium dodecyl sulfate) were 
prepared by the method of Laemmli (22). The gels were 1.5 mm thick. Samples of  con- 
centrated shock fluids were prepared in 1% SDS by heating for 2 min at 100°C. After 
electrophoresis the gels were fixed, stained, and destained by the method of Fairbanks 
(23). The gels were dried on filter paper under vacuum and photographed. 
RESULTS 
Isolation of Mutants in the Branched-Chain Amino Acid Uptake Systems 
D-leucine were mutants with elevated levels of branched-chain amino acid transport (6). 
The mutant allele livR results in failure of L-leucine to  repress the osmotic shock-sensitive 
high-affinity LIV-I and leucine-specific transport systems and their respective binding pro- 
teins, but has no apparent effect on the membrane-bound low-affinity LIV-I1 system 
(6, 10). The lsrR allele, However, results primarily in a derepression of the leucine-specific 
transport system and in the level of  leucine-specific binding protein, with an apparent two- 
fold increase in the LIV-I1 system as well (10 and unpublished experiments). The IstR 
mutation permits the cells t o  utilize lower levels of D-leucine than the livR mutation 
(Table I). Since these 2 distinct patterns of regulation suggested that different functions 
were specified by the livR and lstR alleles, a complementation test was carried out  be- 
tween lsrR and livR mutants. Strains were constructed which were diploid for the E. coli 
chromosome covering the region in which lsrR and livR are located (Fig. 1). Previous work 
had indicated very close linkage between these 2 alleles (10). Both lsrR and livR are reces- 
sive t o  their respective wild-type alleles (Table 11, strains 1 ,  2 , 3 ,  and 5) which therefore 
indicates that they produce a negatively operating, diffusable factor. The merodiploid 
strain listed as number 4 in Table I1 is homozygous for IstR and displays the mutant 
phenotype. Strains homozygous for livR also display the mutant phenotype (10). Strain 
number 6 ,  however, shows that the wild-type alleles of livR and lstR can complement 
Regulatory mutants. Among spontaneous mutants selected for the ability t o  grow on 
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TABLE I. Growth Phenotypes of liv Mutants 
Colonv formationd on  medium suoolemented with 




livR livJ t 
1ivR livK t 
livR livH t 
lstR livH livP - 
aComplete strain descriptions are published elsewhere; all strains are isogenic and carry the derepressed 
transport allele livR (10) except IivH livP, which is in a lstR strain background. 
bDetermined in leu strain background 
CDetermined in leut strain background 
dDetermined after 72-h incubation at 32°C 
TABLE 11. Complementation Analysis of lstR and livR Alleles in F-prime Merogenotes 
Phenotype 
Colony formation, 
Merogenote genotypea L-leucine uptake, nmol/min/mg dry wt. 1,700 pM D-leucine 
- F + +  1. 0.020 
2. 0.012 
3.  0.020 
4. 0.052 t 
t i -  
- 
> F  t +- 
livR t 
F + +  
- 
+ lstR 
F + lstR 
t lstR 
F + lstR - 5. 0.03 + +  
- 
F + lstR 
livR + 6.  0.018 
astrains carrying the F147 gal+ F-prime (35) were constructed from recipients which were, in addition 
to the designated transport alleles, recA gal leu. They were grown on  galactose minimal medium supple- 
mented with 25 pg L-leucine per ml. The F147 istR episome was isolated from a D-leucine utilizing 
homogenoteof a recA+ strain similar in genotype to strain No. 3,  above. 
each other, y ie ld ing  the wild-type phenotype. We conclude from these resul ts  t h a t  ZivR 
and ZstR are separate genes, each cont ro l l ing  a d i f f e r e n t  pattern of regulat ion of the 
branched-chain amino acid uptake systems. The molecular  n a t u r e  of these gene  p r o d u c t s  
is under investigation. 
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Fig. 1. Simplified genetic map of the E. coli chromosome taken from Bachpan, Low, and Taylor (24) 
showing positions of Ziv mutations discussed within. Alleles in parentheses have not been precisely 
mapped. 
Isolation of Mutants Defective in Branched-Chain Amino Acid uptake Systems 
Mutant strains possessing the livR allele have increased wnsitivity to L-valine, which 
inhibits the growth of E. coli K-12 (Table I). Mutations to Gvaline resistance Were induced 
by the mutator phage Mu in strains possessing the livR allele (Table I). A concentration of 
L-valine was chosen which would prevent colony formation only in strains with elevated 
levels of the LIV-I system in order to avoid excessive selective pressure (17). Three bio- 
chemically distinct classes of mutants were found which have been designated livH, livJ, 
and livK (17). These map together by transduction and are closely linked to malT (17 and 
Fig. 1). The transport of L-leucine in these strains has been diminished (Table 111) without 
affecting the transport of other amino acids (17). The mutation livK results in a loss of all 
detectable high-affinity leucine uptake (LIV-I and leucine-specific systems) and a loss of 
the leucine-specific binding protein, both by in vitro activity (Table I) and by SDS- 
polyacrylamide gel electrophoresis (Fig. 2). The LIV-binding protein is still present in these 
strains even though all high-affinity transport is lost. The high-affinity uptake of L-valine 
and L-isoleucine has also been eliminated (17), as has the ability of the cells to utilize 
D-leucine (Table 1). The livJ mutation eliminates the LIV-I high-affinity uptake but the 
leucine-specific system and LIV-I1 system are unaffected. There is a parallel loss of the 
LIV-binding protein activity and the corresponding band on SDS-polyacrylamide gel slabs 
(Table 111 and Fig. 2 ) .  D-Leucine utilization, however, is retained (Table I) indicating that 
the D-leucine utilization phenotype in ZivR and lstR strains is presumably due to a dere- 
pression of the leucine-specific system. The mutation livH eliminates both high-affinity 
transport systems without producing any detectable change in the mobilities or activities 
(Table 111, Fig. 2 and Ref. 17) of the 2 binding proteins. Evidently livH codes for an addi- 
tional factor of high-affinity uptake, at present unidentified. 
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TABLE 111. Transport Phenotypes of liv Mutants 
L-leucine-binding 
Percent of wild-type L-leucine uptake systemsc protein activityd 
Mutationa leucine uptakeb LIV-I Leucine-specific LIV-I1 LIV Leucine-specific 
liv+ 100 t t + t + 
livK 10 - - + + - 
livJ 55 - t + - t 
livH 15 t + + 
livH livP 2 ~ + + 
- - 
- - 
aStrains, same as Table I 
bL-leucine transport was measured at 5 pM L-leucine. 
cThe leucine-specific and LIV-I systems are defined by their low Km (0.1-0.4 pM) for L-leucine; the 
leucine-specific system resists inhibition by L-isoleucine and is responsible for D-leucine uptake. The 
LIV-I1 system has a higher K, (2-4pM) for L-leucine and also transports L-isoleucine and L-valine. 
Presence or absence of a given system was determined by kinetic analysis over substrate ranges from 
0.02 p M  to 20 p M  ( 6 ) .  
dL-leucine-binding activity was measured on crude osmotic shock fluid; the leucine-specific binding 
protein activity was determined by resistance of L-leucine binding to L-isoleucine competition (10). 
A third group of mutants were obtained which were defective in the low-affinity 
(LIV-11) transport system. These mutants were obtained by  inducing a second mutation 
in the livH mutant strain by  mutagenizing the livH strain with ethyl methane sulfonate 
and penicillin-enriching for mutant strains unable t o  utilize low concentrations of L-leucine 
(Table I). One of these mutations has been designated IivP. Conjugational analysis has 
shown that livP is also linked t o  malT (unpublished observations, Fig. 1). Transport of 
L-leucine in the double mutant livH livP has been dramatically lowered over that of the 
parent livH strain (Table III), and kinetic analysis (data not shown) has revealed that the 
LIV-I1 system has been reduced t o  undetectable levels. Thus, in this double mutant strain 
both high- and low-affinity transport systems for leucine have been mutationally eliminated. 
Other workers, however (25, 26) have reported additional low-affinity uptake systems for 
leucine. We are presently characterizing the remaining leucine uptake in the double 
mutant strain t o  ascertain the nature of the residual leucine uptake. 
A genetic complex is suggested for leucine transport genes in E. coli by these studies 
since at  least 4 different genes specifying components of the known transport systems for 
leucine map in the same region. We believe that the structural genes for the leucine-binding 
proteins are part of this complex since a previously reported mutation altering the struc- 
ture of the leucine-specific binding protein (6) also maps in this area (17). We are presently 
characterizing other mutants by complementation analysis and fine mapping t o  better 
define the genetic organization of the region. We are also attempting t o  biochemically 
identify the components coded for by  the livH and livP genes. 
Regulation of Leucine Transport 
activity is highly regulated and responds t o  the level of leucine in the growth medium (6). 
There is a direct relationship between the level of high-affinity leucine transport and the 
Repression by leucine. Early studies showed that high-affinity leucine transport 
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I:ig. 2. Sodium dodecyl sulfate-polyacrylamide gel profile of crude osmotic shock fluid proteins. The 
slab gels were prepared according to the method of Laemmli (22) and were 11% acrylamide. Direction 
of migration is from top to  bottom. A sample of pure LIV-binding protein (LIV-BP) and a trace of the 
leucine-specific binding protein (LS-BP) are shown on  the left; H) shock fluid from a strain carrying the 
liuH mutation, J)  strain with liuJ mutation, and K)  strain with liuH. The wild-type profile (not shown) 
is identical to H. 
level of the leucine-binding proteins (1 7). The correlation between the transport capacity 
and the amount of binding protein shows that the binding proteins are the rate limiting 
component in the transport of leucine into E. coli. When E. coli is grown on nutrient 
medium or minimal medium containing 25-50 pg/ml L-leucine essentially complete re- 
pression of the synthesis of both the LIV and the leucine-specific binding proteins occurs 
and essentially all high-affinity leucine transport is abolished (27) .  
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Separate Regulation of Biosynthesis and Transport of Leucine 
The levels of the leucine biosynthetic enzymes are also regulated by the intracellular 
level of branched-chain amino acids (28). Since both transport and biosynthetic enzymes 
for leucine were repressed by growth on leucine we attempted to determine whether these 
2 processes were regulated in a concerted manner. For these studies we collaborated with 
Dr. Umbarger of Purdue University. We provided Dr. Umbarger with mutant strains that 
were derepressed for leucine transport and he gave us several mutants that were dere- 
pressed for the biosynthetic enzymes of the branched-chain pathway. We examined the 
regulation of leucine transport in strains that were derepressed for biosynthesis (IeuABCD, 
ilvB, iIvADE) as well as a deletion of the entire leucine biosynthetic operon. Leucine trans- 
port activities and leucine-binding protein levels in these strains were regulated in a normal 
manner. Using the transport mutants from our laboratory, Dr. Umbarger showed that the 
regulation of the biosynthetic enzymes for the branched-chain amino acids was not altered 
in mutants with derepressed transport and leucine-binding proteins. The normal regulation 
of transport in E. coli strains with deletions of the entire biosynthetic operon indicated 
that none of the gene products of this operon are required for regulation of transport. We 
concluded from these studies that the transport systems and the biosynthetic enzymes in 
E. coli are not regulated together by a cis-dominant type of mechanism and although both 
systems appear to have components in common it is possible to obtain separate regulatory 
mutations for each system (7, 13). 
Role of Leucyl t R N A  Synthetase in Transport Regulation 
and biosynthesis of leucine is the requirement for aminoacyl tRNA rather than the free 
leucine. Extensive studies in other laboratories have indicated aminoacyl-tRNA synthetases 
are part of the regulatory system for branched-chain amino acid biosynthesis (29). The 
availability of temperature-sensitive mutants for the leucyl-tRNA synthetase (leuSI) per- 
mitted us to determine whether this enzyme was also involved in the regulation of the 
transport of leucine. We examined both the level of transport activity and the level of the 
periplasmic-binding proteins in the temperature-sensitive mutant strain (leuS1) grown at 
the permissive temperature (36°C) and the nonpermissive temperature (41 "C). Strain 
EB143 has a complete deletion of the leucine biosynthetic operon which avoids the in- 
creased endogenous levels of leucine that would be produced in a prototrophic temperature 
sensitive IeuS strain grown at 41°C. Strain EB144 served as the isogenic non-temperature- 
sensitive control strain. The results are presented in Table IV. When mutant strain EB143 
was shifted from 36 to 41°C the transport activity for leucine, isoleucine, and valine was 
greatly increased. Little effect was observed for proline or histidine uptake. Proline is trans- 
ported by a membrane-bound transport system that derives its energy from the membrane 
potential while histidine is transported by a periplasmic-binding protein system and derives 
its energy more directly from ATP. The derepression of threonine deaminase that was 
observed for strain EB143 when it was shifted to 41°C was the expected response of a 
branched-chain amino acid biosynthetic enzyme which is subject to multivalent repression. 
The branched-chain amino acid transport system responds only to changes in the leucine 
level. Isoleucine and valine t RNA synthetase mutants did not produce regulatory changes 
in the transport activity. The shock fluid of strains EB143 and EB144 were examined for 
leucine-binding proteins when the cells were grown at 41°C. There is a fivefold derepression 
in the synthesis of the binding proteins for leucine when the temperature is shifted to 41°C 
A possible candidate for a common component in the regulation of both transport 
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TABLE 1V. Expression of Transport and a Biosynthetic Enzyme Activity in Strains EB143 and 
EB144 
Strain 
Growth Transport activitiesb Threonine 
conditionsa Leu I le Val dcaminasec 
EB 143, ura-leu a1 101, IeuSl 36°C 100 65 87 26 
EB144, ara-leii~l101 36°C 87 61 70 16 
E,0 143, ura-leii~llO1 leu S l  41°C 470 773 904 450 
EB 144, aru-lennl I01 41°C 96 70 74 41 
G r o w t h  in glucose-basal salts medium plus 0.2 mM L-leucine. 
bTransport was assayed a t  1 pM leucine (Leu) or isoleucine (He) and 3 p M  valine (Val). One hundred 
percent represents 0.23 mmol leucine taken up per min per kg cells dry weight. 
CSpecific activity represents pmol of a-ketobutyrate formed per min/g of cellular protein. The growth 
media included 0.4 mM L-leucine and L-isoleucine and 1 mM L-valine. 
with little change in the control strain. These results were consistent with a role of the 
binding proteins in the rate limiting step in leucine transport and further indicated that the 
synthesis of the binding proteins is regulated by the level of modified leucyl-tRNA or the 
leucyl-tRNA synthetase. We obtained a mutant strain with a defect in the  maturation of 
leucyl-tRNA to distinguish between these 2 alternatives. 
Role of hisT Gene Product 
The hisT locus codes for an enzyme that converts uridine to  pseudouridine in the 
tRNAs for leucine, histidine, and tyrosine. The regulation of biosynthetic enzymes for 
these 3 amino acids is no longer sensitive t o  their cognate amino acids in strains containing 
a kisT mutation (1 1). We obtained E. coli strains containing a hisT mutation from Drs. 
R. P. Lawther and W. Hatfield. An examination of leucine transport activity in the hisT 
strain showed that the regulation was abnormal.The hisT strain showed a higher transport 
of leucine than the parental strain when grown under repressing conditions and further- 
more it failed t o  derepress leucine transport activity when grown under conditions of 
leucine limitation. Under these same conditions the biosynthetic pathway for leucine also 
does not show a repression or derepression regulation (Quay SC, unpublished observations). 
We reported similar results for a role of  the hisT gene product in the regulation of  leucine 
transport activity in Salmonella typhimurium (13). The results of these 2 studies with 
hisT strains provide evidence that the repression of transport of  leucine requires fully 
maturated t RNA which is aminoacylated with leucine. 
Role of rho in Transport Regulation 
Recent reports have shown that several of the biosynthetic operons in bacteria con- 
tain an “attenuator” site near the operator region that acts as a barrier t o  transcription by 
RNA polymerase (1 5, 16). The termination factor rho has been implicated in attenuator 
function. To test if transport for leucine, isoleucine, and valine is under an attenuator-type 
regulation 2 strains were obtained from Dr. Umbarger of Purdue University, which were 
leucine auxotrophs with one having a suA120 allele (1 4). The mAl2O allele is a missense muta- 
tion in the rho factor (33) .  The initial rate of transport of 8 amino acids was measured in 
M A M T : 2 8 9  
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TABLE V. Effect of a Mutation in Termination Factor rho on Amino Acid Transport 






Arginine (3 pM) 
Glutarnine (1 pM) 
Histidine (1 pM) 
Isoleucine ( 1  pM) 
Leucine (1 pM) 
Proline (3 pM) 
Tryptophan (3  pM) 

















"Cells were grown in MOPS-G, 0.2 mM leucine, and 25 rng/liter tryptophan. Cells were harvested and 
transport assayed as described previously (9). 
the rho mutant and the isogenic parental strain. The data are presented in Table V. The 
uptake of leucine, isoleucine, and valine is increased twofold even though leucine is present 
in the growth medium. Arginine and histidine transport activity is also increased in the 
rho mutant. Tryptophan and proline uptake is unchanged but glutamine is greatly de- 
creased. The kinetics of uptake showed that the K, values for both the high- and the low- 
affinity transport systems for leucine in the rho mutant were similar to those obtained for 
the parental strain. The V,,, value for the high-affinity leucine uptake was increased 
approximately eightfold in the rho mutant. The V,,,,of the low-affinity system was only 
slightly elevated. 
An examination of the leucine-binding activity in the osmotic shock fluid was 
carried out. The leucine-binding activity showed a fourfold increase in the rho mutant. In 
a similar manner the histidine- and arginine-binding activities in the osmotic shock fluid 
were increased somewhat while glutamine-binding activity decreased significantly. These 
results show that rho-dependent transcriptional termination is important for leucine- 
specific repression of branched-chain amino acid transport (14). 
Leuci ne Sensitivity 
transport system for leucine is responsible for greatly increased sensitivity toward growth 
inhibition by leucine, valine, serine, and certain analogues such as 4-azaleucine or 
5',5',5'-trifluoroleucine (31). We recently showed that the ability of the LIV-I transport 
system to carry out exchange of endogenous amino acids for extracellular leucine is a 
major factor in leucine sensitivity. When E. coli cells are shifted from nutrient medium to 
minimal medium containing leucine a long lag time in the resumption of growth is observed. 
The lag time in the growth represents the time required to derepress certain biosynthetic 
enzymes. Added isoleucine antagonizes the leucine sensitivity showing that the necessary 
derepression of the biosynthesis of isoleucine is prevented by leucine. We were able to 
show that the necessary biosynthetic enzymes for isoleucine cannot by synthesized. The 
high-affinity transport system serves for rapid exchange of branched-chain amino acids 
while the low-affinity system does not produce significant exchange of these amino acids. 
The ZivR locus, which leads to  a trans-recessive derepression of the high-affinity 
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These results provide a mechanism for leucine sensitivity and explain the increased sensi- 
tivity of strains with derepressed high-affinity transport such as that shown by the ZivR 
mutant strain. 
DISCUSSION 
The results presented above describe the 2 types of active transport systems in E. 
coli for the branched-chain amino acids. One type is membrane bound and can be observed 
in membrane vesicles (LIV-II), and the other type is osmotic-shock sensitive and requires 
binding proteins t o  produce active transport of leucine (LIV-I). A regulatory genetic locus, 
livR, at  minute 22 on the E. coli chromosome produces negatively regulated leucine trans- 
port and synthesis of the leucine-binding proteins. Valine-resistant strains that were still 
sensitive to  the dipeptide glycylvaline were selected as potential LIV-I transport mutants. 
Among the valine-resistant mutants we identified a LIV-binding protein mutant (ZivJ), a 
leucine-specific binding protein mutant (livK), and a nonbinding protein component of the 
LIV-I system (livH). A fourth mutation, livP, appears t o  be a component of the low-affinity 
LIV-I1 system. Since a livP mutant appears to  have normal LIV-1 transport we have con- 
cluded that the LIV-I and LIV-11 systems represent parallel systems even though they may 
have certain components in common. These mutations concerned with leucine transport 
form a cluster closely linked t o  rrzalT at minute 74 on the E. coli chromosome. The positions 
of these mutations are distinctly different from that of bmQ, brrzR, and brnS mutations 
of branched-chain amino acid transport described by laccarino and co-workers (26). 
Continued studies of the chemical and physical properties of the LIV- and leucine- 
specific binding proteins are being carried out in collaboration with other laboratories. 
Dr. Ovchinnikov and co-workers of Moscow, USSR, have recently published the complete 
amino acid sequence of the LIV-binding protein (32) and are currently sequencing the 
leucine-specific binding protein which is structurally very similar. Antonov et al. (33) 
have shown that a concentration-dependent reversible association of the LIV-binding 
protein may occur producing aggregates with an apparent molecular weight up t o  300,000. 
The presence of these aggregates has been correlated with nonlinear Scatchard plots of 
leucine-binding activity. Alternative explanations for nonlinear Scatchard plots of leucine 
binding t o  the LIV-binding protein have been offered by Anraku and co-workers (34). 
These studies suggest that binding protein preparations contain bound ligand which could 
alter the specific activity of added ligand at high protein t o  ligand ratios. 
which responds t o  the level of leucine added t o  the medium. Modified leucyl-tRNA ap- 
pears to  play a role in the regulation along with the transcription termination factor rho. 
The results of this study suggest an attenuator site may be operative in the regulation of 
high-affinity leucine transport. This complex regulatory system for transport of leucine is 
similar t o  that of its biosynthe.sis suggesting the important role of the LIV-I transport 
system to the physiology of the bacterial cell. Since changes in isoleucine or  valine levels 
do not produce regulatory changes in LIV-I a special role of leucine in the physiology of 
E. coli is implied. The properties of the LIV-I system that give rise t o  a rapid exchange of 
leucine for isoleucine, thus creating isoleucine pseudoauxotrophy under certain conditions, 
have helped t o  explain the leucine sensitivity of E. coli (31). This complex regulatory 
system for the transport of leucine which is similar t o  that of  the biosynthetic enzymes 
provides an example of the important role transport systems can play in amino acid 
metabolism. 
Figure 3 presents a scheme of  the regulatory components of  the LIV-I transport system 
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Fig. 3. Model of leucine transport regulation in E. coli 
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